Search

everythinglearnresearchcommunity

for

Search:↓

L-threonate may help prevent balding by blocking a key hair loss factor.

Researchers found a new mutation in the EDA gene that likely causes missing teeth and mild skin symptoms in one family.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The root extract of Untica mairei Levl may help treat benign prostatic hyperplasia.

The research found enzymes in Stephania epigaea that help make cepharanthine.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Plant-based treatments might help with hair loss and have fewer side effects than synthetic drugs.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.